Ali Bohlok1, Theo Richet2, Marie Quiriny2, Esther Willemse2, Cécile Dekeyser2, Guy Andry2, Vincent Donckier2, Antoine Digonnet2. 1. Department of Surgical Oncology, Institut J. Bordet, Université Libre de Bruxelles, 121, Boulevard de Waterloo, 1000, Brussels, Belgium. Ali.Bohlok@bordet.be. 2. Department of Surgical Oncology, Institut J. Bordet, Université Libre de Bruxelles, 121, Boulevard de Waterloo, 1000, Brussels, Belgium.
Abstract
INTRODUCTION: The aim of this retrospective study was to assess the efficacy of Salivary Bypass Tube (SBT) for preventing pharyngo-cutaneous fistula (PCF) in a recent cohort of patients who underwent primary and salvage total laryngectomy (TL). METHODS: A consecutive series of 133 patients who underwent total laryngectomy between 1997 and 2019 was reviewed. The incidence of PCF was compared between patients who did not receive SBT (nSBT group; n = 55) and those preventively receiving SBT (SBT group; n = 78) in both primary and salvage TL. Risk factors for PCF were evaluated in a univariate and multivariate analyses. RESULTS: The overall PCF rate was 30%. Preoperative characteristics were similar between the nSBT and SBT groups, except for older age (p = 0.016), lower preoperative hemoglobin (p = 0.043), and lesser neoadjuvant chemotherapy (p = 0.015) in the SBT group. The rate of PCF the nSBT group, was 41.5%, compared to 21.8% in the SBT group (p = 0.020). In multivariate analysis, only the use of SBT was associated with lower risk of PCF (OR = 0.41 (95% CI 0.19-0.89), p = 0.026). This effect was verified only in the subgroup of patient operated for salvage TL (OR = 0.225; 95% CI 0.09-0.7; p = 0.008). CONCLUSION: The use of SBT in our series in salvage TL, appears to be associated with a decreased risk of PCF.
INTRODUCTION: The aim of this retrospective study was to assess the efficacy of Salivary Bypass Tube (SBT) for preventing pharyngo-cutaneous fistula (PCF) in a recent cohort of patients who underwent primary and salvage total laryngectomy (TL). METHODS: A consecutive series of 133 patients who underwent total laryngectomy between 1997 and 2019 was reviewed. The incidence of PCF was compared between patients who did not receive SBT (nSBT group; n = 55) and those preventively receiving SBT (SBT group; n = 78) in both primary and salvage TL. Risk factors for PCF were evaluated in a univariate and multivariate analyses. RESULTS: The overall PCF rate was 30%. Preoperative characteristics were similar between the nSBT and SBT groups, except for older age (p = 0.016), lower preoperative hemoglobin (p = 0.043), and lesser neoadjuvant chemotherapy (p = 0.015) in the SBT group. The rate of PCF the nSBT group, was 41.5%, compared to 21.8% in the SBT group (p = 0.020). In multivariate analysis, only the use of SBT was associated with lower risk of PCF (OR = 0.41 (95% CI 0.19-0.89), p = 0.026). This effect was verified only in the subgroup of patient operated for salvage TL (OR = 0.225; 95% CI 0.09-0.7; p = 0.008). CONCLUSION: The use of SBT in our series in salvage TL, appears to be associated with a decreased risk of PCF.
Authors: Hilliary N White; Blake Golden; Larissa Sweeny; William R Carroll; Jeffery S Magnuson; Eben L Rosenthal Journal: Laryngoscope Date: 2012-05-30 Impact factor: 3.325
Authors: Ian Ganly; Snehal Patel; Jeanette Matsuo; Bhuvanesh Singh; Dennis Kraus; Jay Boyle; Richard Wong; Nancy Lee; David G Pfister; Ashok Shaha; Jatin Shah Journal: Cancer Date: 2005-05-15 Impact factor: 6.860
Authors: Cai Grau; Lars Vendelbo Johansen; Hanne Sand Hansen; Elo Andersen; Christian Godballe; Lisbeth Juhler Andersen; Jesper Hald; Henrik Møller; Marie Overgaard; Lars Bastholt; Ole Greisen; Grethe Harbo; Olfred Hansen; Jens Overgaard Journal: Head Neck Date: 2003-09 Impact factor: 3.147
Authors: Paolo Boscolo-Rizzo; Giuseppe De Cillis; Carlo Marchiori; Silvia Carpenè; Maria Cristina Da Mosto Journal: Eur Arch Otorhinolaryngol Date: 2008-02-05 Impact factor: 3.236